157 related articles for article (PubMed ID: 30621480)
1. Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles.
Zhu HZ; Hou J; Guo Y; Liu X; Jiang FL; Chen GP; Pang XF; Sun JG; Chen ZT
Drug Deliv; 2018 Nov; 25(1):1974-1983. PubMed ID: 30621480
[TBL] [Abstract][Full Text] [Related]
2. Detection of miR-155-5p and imaging lung cancer for early diagnosis: in vitro and in vivo study.
Zhu HZ; Fang CJ; Guo Y; Zhang Q; Huang LM; Qiu D; Chen GP; Pang XF; Hu JJ; Sun JG; Chen ZT
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1941-1951. PubMed ID: 32447486
[TBL] [Abstract][Full Text] [Related]
3. Chitosan combined with molecular beacon for mir-155 detection and imaging in lung cancer.
Zhu HZ; An JH; Yao Q; Han J; Li XT; Jiang FL; Chen GP; Peng LN; Li YS; Sun JG; Chen ZT
Molecules; 2014 Sep; 19(9):14710-22. PubMed ID: 25230125
[TBL] [Abstract][Full Text] [Related]
4. In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery.
Zou A; Chen Y; Huo M; Wang J; Zhang Y; Zhou J; Zhang Q
J Pharm Sci; 2013 Jan; 102(1):126-35. PubMed ID: 23073894
[TBL] [Abstract][Full Text] [Related]
5. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
[TBL] [Abstract][Full Text] [Related]
6. Octreotide Functionalized Nano-Contrast Agent for Targeted Magnetic Resonance Imaging.
Jackson AW; Chandrasekharan P; Ramasamy B; Goggi J; Chuang KH; He T; Robins EG
Biomacromolecules; 2016 Dec; 17(12):3902-3910. PubMed ID: 27936729
[TBL] [Abstract][Full Text] [Related]
7. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
8. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models.
Zhang J; Jin W; Wang X; Wang J; Zhang X; Zhang Q
Mol Pharm; 2010 Aug; 7(4):1159-68. PubMed ID: 20524673
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of
Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
[TBL] [Abstract][Full Text] [Related]
10. Multimodality imaging of naturally active melanin nanoparticles targeting somatostatin receptor subtype 2 in human small-cell lung cancer.
Xia L; Guo X; Liu T; Xu X; Jiang J; Wang F; Cheng Z; Zhu H; Yang Z
Nanoscale; 2019 Aug; 11(30):14400-14409. PubMed ID: 31334537
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
Shen H; Hu D; Du J; Wang X; Liu Y; Wang Y; Wei JM; Ma D; Wang P; Li L
Eur J Pharmacol; 2008 Dec; 601(1-3):23-9. PubMed ID: 18983839
[TBL] [Abstract][Full Text] [Related]
12. Octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles as potential carriers for targeted antitumor drug delivery.
Zou A; Huo M; Zhang Y; Zhou J; Yin X; Yao C; Zhu Q; Zhang M; Ren J; Zhang Q
J Pharm Sci; 2012 Feb; 101(2):627-40. PubMed ID: 22083725
[TBL] [Abstract][Full Text] [Related]
13. [Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].
Shen HC; Wang XW; Liu YG
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2498-503. PubMed ID: 19080633
[TBL] [Abstract][Full Text] [Related]
14. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
[TBL] [Abstract][Full Text] [Related]
17. Using Dual Fluorescence Reporting Genes to Establish an In Vivo Imaging Model of Orthotopic Lung Adenocarcinoma in Mice.
Lai CW; Chen HL; Yen CC; Wang JL; Yang SH; Chen CM
Mol Imaging Biol; 2016 Dec; 18(6):849-859. PubMed ID: 27197534
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.
Zhang X; Yang C; Zhou J; Huo M
Small; 2016 Jul; 12(26):3578-90. PubMed ID: 27244649
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle.
Kim JK; Choi KJ; Lee M; Jo MH; Kim S
Biomaterials; 2012 Jan; 33(1):207-17. PubMed ID: 21944470
[TBL] [Abstract][Full Text] [Related]
20. [99mTc-octreotide receptor scintigraphy in NCI-H446 small cell lung cancer nude mice model].
Li C; Zuo S; Wang X; Liu X; Wang G; Wu F
Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):1-7. PubMed ID: 25603866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
